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Abstract Insulin increases glucose uptake by promoting the 
translocation of the GLUT4 isoform of glucose transporters to 
the plasma membrane. We have studied this process in living 
single cells by fusing green fluorescent protein (GFP) to the N- 
terminus (GFP.GLUT4) or C-terminus (GLUT4.GFP) of 
GLUT4. Both chimeras were expressed in a perinuclear 
compartment of CHO cells, and in a vesicular distribution 
through the cytosol. Insulin promoted an increase in plasma 
membrane fluorescence as a result of net translocation of the 
chimeras to the cell surface. GLUT4-GFP, but not 
GFP.GLUT4, was re-internalised upon the removal of insulin 
suggesting that a critical internalisation signal sequence xists in 
the N-terminus of GLUT4. The use of GFP thus allows an 
analysis of GLUT4 trafficking in single living cells. 
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fluorescent protein 
1. Introduction 
Insulin stimulates glucose uptake into adipocytes and mus- 
cle cells by virtue of an insulin-regulatable g ucose transpor- 
ter, GLUT4. The translocation of this transporter f om an 
intracellular location to the cell surface in response to insulin 
is largely responsible for the 20- to 30-fold increase in glucose 
transport observed in these cells (for review see [1 3]). How- 
ever, the exact intracellular location of GLUT4 in the basal 
state and the mechanism by which it reaches the cell surface 
upon insulin stimulation are unclear. Under basal or non- 
stimulated conditions more than 95% of the GLUT4 is loca- 
lised to tubular vesicular elements that are found clustered 
adjacent to early or late endosomes, in the trans Golgi reticu- 
lure (TGR) or in the cytoplasm often close to the plasma 
membrane. The level of GLUT4 is decreased by 40-50% at 
each of these locations by insulin, suggesting that all of these 
compartments participate in the insulin regulated recycling of 
GLUT4 [4,5]. Immuno-electron microscopy (EM) studies of 
GLUT4 in adipocytes have further shown that GLUT4 is 
located, at least in part, within the endocytic system as it 
undergoes constitutive recycling through clathrin-coated pits 
[5,6]. 
Several approaches have been used to 'tag' GLUT4 and 
monitor its subcellular location and/or recycling. These in- 
clude immunogold electron microscopy [4,5], and radiola- 
belled membrane-impermeant glucose transporter-specific 
photolabels that have been developed which irreversibly 
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bind GLUT4 upon exposure to UV light [7 9]. While studies 
using such 'tags' are highly informative, they are limited by 
several key factors. Firstly, immuno-EM cannot provide in- 
formation on the dynamics of the translocation event as cells 
must be processed, fixed and labelled. Photolabels are limited 
by their inability to distinguish between the various isoforms 
of glucose transporter, the multiple intracellular pools of 
GLUT4, and also the need to solubilise cells and immunopre- 
cipitate GLUT4 to quantitate changes in distribution [10,11]. 
Indeed, all of these methodologies ultimately rely on cellular 
disruption prior to analysis. An alternative approach, whereby 
cell surface glucose transporters can be detected with an epi- 
tope tag within the first exofacial loop [12,13], again provides 
only a static picture of the localisation of the transporter at 
the cell surface and provides no information on the intracel- 
lular distribution. To circumvent these problems, we sought o 
develop a system which would allow us to monitor GLUT4 
translocation i real time in living cells. Such a system will 
have wide implications for the analysis of GLUT4 trafficking, 
recycling and the signalling mechanisms involved. 
The system involves the use of the Aequoria victoria green 
fluorescent protein (GFP). The expression of this intrinsically 
fluorescent protein in mammalian cells has generated a con- 
siderable amount of interest in the use of this molecule to 'tag' 
intracellular proteins which can be monitored in situ [14-17]. 
There are some reports of the successful expression of GFP- 
fusion proteins in mammalian cells, for example with the 
NMDA receptor [18], MAP4 [19] and cyclins [20]. However, 
the extent o which GFP, which is a relatively large (27 kDa) 
protein, might interfere with the normal regulatable trafficking 
of a protein in mammalian cells has not been adequately 
addressed. 
We have prepared two chimeras, with GFP fused either to 
the amino- or carboxyl-terminal ends of GLUT4. Both chim- 
eras exhibit a distribution characteristic of GLUT4 in several 
cell types. Upon exposure of cells expressing either chimera to 
insulin, we observed their translocation to the plasma mem- 
brane. Of particular interest was the observation that re-inter- 
nalisation of the transporter upon insulin removal was pre- 
vented by fusing GFP to the N-terminus but not C-terminus 
of GLUT4. The results are discussed in terms of a molecular 
model for transporter t anslocation and recycling. 
2. Materials and methods 
2.1. Materials 
Oligonucleotides were synthesised bythe University of Bristol Mo- 
lecular Recognition Centre. Unless otherwise stated all other biochem- 
ical reagents were either from Sigma (Poole, Dorset, UK) or BDH 
(Poole, Dorset, UK). Tissue culture media nd foetal calf serum were 
from Gibco (Paisley, UK). pGFP was generated by subcloning the 
cDNA encoding the wild-type sequence ofGFP from the vector TU65 
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(a generous gift of Dr M. Chalfie, Columbia University [14]) into the 
mammalian expression vector pcDNAneoI (Invitrogen, San Diego, 
CA). Rabbit polyclonal antibodies raised against a synthetic peptide 
encoding the C-terminal 14 amino acid residues of the human isoform 
of GLUT4 have been described previously [21]. Antibody 9El0 reac- 
tive against he epitope MEQKLISEEDLK was a gift of H. Patterson 
[22] (Chester Beatty Laboratories, London). 
2.2. Plasmid construction 
The plasmids TU65 and pSPGT4 [23] were used as templates for 
PCR amplification of the wild-type GFP and GLUT4 sequences. This 
was achieved as follows. 
For the N-terminal GFP fusion (GFP.GLUT4), the GFP cDNA 
was amplified with the sense primer TTTAAGCTTGACGAGATG- 
GAGCAGAAGCTGATCTCGGAGGAGGACCTGAAGAGTAAA- 
GGAGAAGAA (possesses a 5' HindIlI site followed by a Kozak 
initiation sequence, initiating methionine, epitope for recognition by 
antibody 9El0 (underlined) and five codons complimentary to amino 
acids 2-6 of wild-type GFP) and antisense primer TTTTGGAT- 
CCTTTGTATAGTTCATC (possesses a 5' BamHI site and five co- 
dons complimentary to the amino acids 234-238 of GFP). The 
GLUT4 cDNA was amplified using sense primer TTTTGGATC- 
CCCGTCGGGCTTCCAA (possesses a 5' BamH| site followed by 
the first five amino acids of GLUT4 excluding the initiating methio- 
nine) and antisense primer TTTTTCTAGATCAGTCGTTCTCATC 
(possesses a 5' XbaI site followed by the final five amino acids of 
GLUT4, including the stop codon). The GFP containing PCR prod- 
uct was digested with HindIII and BamHI, and ligated into the Hin- 
dIII BamHl site of the mammalian expression vector pcDNAneoI. 
This plasmid was then digested with BamHI and XbaI and ligated 
with the GLUT4 PCR product which had been similarly digested 
with BamHI and XbaI. 
For the C-terminal GFP fusion (GLUT4.GFP), the GLUT4 cDNA 
was amplified with the sense primer TTTTAAGCTTGACGA- 
GATGCCGTCG (possesses a 5' HindIII site followed by a Kozak 
initiation sequence and three codons complimentary to amino acids 1 
3 of GLUT4) and antisense primer TTTTGGATCCGTCGTTCT- 
CATCTGG (possesses a 5' BamHI site and five codons complimen- 
tary to amino acids 505 509 of GLUT4). The GFP cDNA was am- 
plified using sense primer TTTTGGATCCAGTAAAGGAGAAGAA 
(possesses a 5' BamHI site followed by amino acids 2 6 of GFP) and 
antisense primer TTTTTCTAGATCACTTCAGGTCCTCCTCCGA- 
GATCAGCTTCTGCTCCATTTTGTATAGTTCATC (possesses a 
5' XbaI site followed by the epitope for antibody 9El0 which is under- 
lined, and the final five amino acids of GFP and includes a stop 
codon). The GFP containing PCR product was digested with BamHI 
and XbaI and ligated into the BamHI-XbaI site of pcDNAneol. The 
resulting plasmid was then digested with HindIII and BamHI, and 
ligated with the GLUT4 PCR product which had been similarly di- 
gested with HindlII BamHI. 
The sequences encoding the final fusion proteins were re-sequenced 
in their entirety to confirm the absence of spurious mutations, and 
were purified by banding on two successive CsC1 gradients. The re- 
sulting plasmid products were resuspended in 2 mM Tris-HCl, 0.2 
mM EDTA, pH 8.0. 
2.3. Cell microinjection 
CHO.T cells, which over-express the human insulin receptor, were 
seeded onto glass coverslips and were incubated in 60 mm diameter 
petri dishes in growth medium (Ham's FI2 medium supplemented 
with 5% foetal calf serum, I0 mM Hepes, 200 U.m1-1 benzylpenicillin, 
100 ~tg-m1-1 streptomycin and 250 ~tg-ml 1 6418) and cultured at 
37°C in an atmosphere of 5% CO2 until approx. 80'¼, confluent. 
The plasmids containing the chimeras (200 gg/ml, in 2 mM Tris- 
HCI, pH 8.0, 0.2 mM EDTA) were microinjected into cells in 
DMEM supplemented with 5% foetal calf serum, 25 mM Hepes, 
200 U-ml 1 benzylpenicillin, 100 /ag.ml - l  streptomycin and 2 mM 
NaHCO3. Cells were then incubated in growth medium for 16 24 h 
prior to experiments. 
2.4. Fluorescence analysis 
Microinjected cells were serum starved for 2 h prior to fluorescence 
analysis in Hepes-buffered Krebs (10 mM Hepes, pH 7.4, 2 mM 
NaHCO3, 140 mM NaCI, 3.6 mM KC1, 0.6 mM Na2HPO~, 0.5 
mM MgSO4, 1 mM CaCI2 and 5.5 mM glucose) using a Zeiss Ax- 
iovert 100TV microscope with a 40× oil-immersion objective, and a 
cooled charge couple device camera (Photonic Science, UK) with 
BioVision image analysis oftware (Improvision, University of War- 
wick Science Park, UK). GFP exitation/emission was achieved with a 
High Q FITC filter set (41001; Chroma Technology Corp. Brattle- 
boro, VT). If required, the cells were then further incubated as de- 
scribed in the figure legends and re-imaged, 
For immunofluorescence analysis, the cells were fixed in 4% para- 
formaldehyde in PBS for 20 rain and permeabilised with 0.015% sa- 
ponin in PBS for 10 min. This, and subsequent s eps, were performed 
at room temperature. The cells were blocked with 3% bovine serum 
albumin in PBS (BSA/PBS) for 15 min and then incubated in BSA/ 
PBS containing 1:100 dilution of anti-Myc antibody 9El0 [22] for 1 h. 
Cells were washed 3 times for 5 min in PBS and incubated in 1:100 
dilution of a rhodamine-conjugated goat anti-mouse IgG (Dako, Den- 
mark) in BSA/PBS for 1 h. After extensive washing in PBS the cover- 
slips were mounted in Mowiol and fluorescence imaging performed as 
described above but with Zeiss filter set 14 for excitation/emission. 
3. Results 
Two GLUT4 fusion proteins were generated which con- 
tained the entire coding sequence of GLUT4 with GFP  fused 
either at the N- or C-terminus. For the sake of simplicity we 
will refer to the fusion constructs as pGFP 'GLUT4 and 
pGLUT4"GFP,  respectively. An epitope tag was engineered 
into the fusion proteins either at the very N-terminus of 
GFP .GLUT4,  or C-terminus of GLUT4.GFP.  This epitope 
is based on the amino sequence recognised by the monoclonal  
ant i -Myc ant ibody 9El0,  and was incorporated to allow ad- 
dit ional analysis by immunofluorescence staining of fixed and 
permeabil ised cells. 
3.1. Expression of  GFP.GLUT4 and GLUT4"GFP in 
CHO" T cells 
We used CHO cells that over-express human insulin recep- 
tors (CHO'T) because they allow the greatest level of GFP  
fluorescence. In our hands, GFP  exhibits considerably lower 
levels of fluorescence in other types of f ibroblast (e.g. 3T3-L1), 
and no detectable fluorescence in PC12 cells (S.D. and J.M.T., 
unpubl ished ata). It is not clear why GFP  exhibits such a 
wide variety of different levels of fluorescence intensity; it may 
be related to the redox state of the cell, small variations in 
intracellular pH, differences in oxygen tension or expression 
of chaperonins. Whatever the reason, the experiments de- 
scribed below were only possible in the CHO cell background. 
When native GFP  is expressed in CHO.T cells it exhibits a 
diffuse distribution throughout  he cell but with a slight con- 
centration in the nucleus and exclusion from nucleoli (Fig. 
la). By contrast, fluorescence was detected in the perinuclear 
region of cells expressing either the GLUT4.GFP  (Fig. lb) or 
GFP .GLUT4 (Fig. lc) chimeras. A punctate and vesicular- 
like distr ibution was also observed throughout  he cytosol 
(Fig. lb,c and see also below). Both chimeras were excluded 
from the nucleus, and the plasma membrane was devoid of 
any significant fluorescence. That  the chimeras were excluded 
from the nucleus strongly suggests that they were intact, and 
that the junct ion between the two proteins was not susceptible 
to proteolysis to generate native GFP.  Consistent with this, 
we found that GFP .GLUT4 over-expressed in COS cells ex- 
hibited an apparent Mr of approx. 70 90 kDa (data not 
shown). This represented a shift in Mr of approx. 2040 
kDa when compared to native GLUT4,  and was the expected 
increase in molecular weight of the chimera considering the 
molecular mass of GFP  is 27 kDa. 
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Fig. 1. Expression of GFP'GLUT4 and GLUT4.GFP in CHO'T cells: comparison with native GFP. CHO.T cells were microinjected with 
pGFP (a,d), pGLUT4.GFP (b,e) or pGFP.GLUT4 (c,f) cDNAs. The cells were incubated in complete medium for 24 h before taking a fluor- 
esence (a-c), or bright-field (d f) images, The bar represents 10 ~tm. 
In some experiments a very bright and localised region of 
fluoresence was also observed close to the nucleus and over- 
lapping with the perinuclear distribution described above (see 
Fig. 2a~t). This bright, almost circular area of fluoresence, 
suggests ome expression at, or close to, the microtubule or- 
ganising centre. 
We noted that if the ceils were incubated for longer than 48 
h after microinjection, the intensity of plasma membrane 
fluorescence increased ramatically (data not shown). This 
suggests that as the expression level of the chimeras increases 
beyond a threshold level, the chimeras may leak out of the 
intracellular compartment and into the plasma membrane. 
Thus, the intracellular compartment can only retain a finite 
amount of chimeric transporter. All subsequent experiments 
were thus performed within 24 h of microinjection. 
3.2. Insulin stimulates translocation of  both GLUT4 chimeras 
to the plasma membrane 
We next assessed the effect of insulin on the translocation f
the chimeras to the plasma membrane. Cells expressing either 
GLUT4.GFP or GFP.GLUT4 were imaged prior to treatment 
with insulin. As shown in the top set of panels in Fig. 2, the 
distribution of the transporters in the basal state was similar 
to that shown in Fig. 1. The two cells shown in Fig. 2a,b 
exhibited an increased plasma membrane fluorescence after 
treatment with insulin (e and f, respectively). Very similar 
results were obtained with the GFP.GLUT4 chimera (com- 
pare c and d with g and h, respectively). 
In the absence of insulin, we consistently observed a pro- 
portion of cells (20 + 5%; mean + SEM of three separate x- 
periments) that exhibited pronounced plasma membrane-loca- 
lised GLUT4 chimeras. The addition of insulin for 1 h 
increased this proportion of cells to 49 + 3%. Thus approxi- 
mately half of the cells did not respond to insulin as judged by 
this criterion. However, the non-responsive c lls did express 
insulin receptors as they immunostained with a monoclonal 
anti-insulin receptor antibody (data not shown). 
To confirm that insulin promoted a net translocation of the 
GLUT4 chimeras to the plasma membrane, we stained fixed 
and permeabilised cells expressing GFP'GLUT4 with the 
monoclonal ntibody 9El0 which recognises the short peptide 










Fig. 2. Effect of insulin on the subcellular distribution of GFP.GLUT4 and GLUT4.GFP chimeras in living CHO.T cells. CHO.T cells were mi- 
croinjected with pGLUT4.GFP (a,b,e,f) or pGFP-GLUT4 (c,d,g,h) and incubated in complete medium for 16 h. The cells were incubated in ser- 
um-free Ham's F12 medium for 2 h, and a basal fluorescence image then taken in Krebs medium (~d). The cells were incubated in serum-free 
Ham's F12 medium containing 200 nM insulin and a second fluorescence image of the same cells in panels a~t were taken 1 h later in Krebs 
medium (e-h, respectively). The bar represents 10 gm. 
in Fig. 3, insulin treatment of the cells did indeed promote an 
increase in immunoreact ive chimera at the plasma membrane. 
3.3. Endocytosis o f  GLUT4 chimeras upon insulin removal 
We next examined the ability of the chimeras to re-inter- 
nalise upon subsequent removal of insulin. To do this, we 
treated cells expressing GLUT4.GFP  or GFP .GLUT4 with 
insulin for 1 h at 37°C. Fluorescence analysis of cells con- 
firmed translocation of each chimera to the plasma membrane 
(Fig. 4a~d). Insulin was removed, and the cells further incu- 
bated overnight at 20°C. This lower temperature was used to 
prevent he build up in expression that causes the chimeras to 
leak out to the plasma membrane after 48 h at 37°C (see 
discussion above). 
The GLUT4.GFP  chimera exhibited almost complete re- 
internalisation upon insulin removal (compare Fig. 4a with 
e, and b with f). When these cells were subsequently re-chal- 
lenged with insulin for 1 h at 37°C, the GLUT4.GFP  chimera 
returned to the plasma membrane demonstrat ing that the e f  
fect was fully reversible (data not shown). In contrast, we 
observed no detectable re-internalisation of the GFP-GLUT4 
chimera (compare Fig. 4c with g, and d with h). 
4. Discussion 
The cloning of GFP,  and the ability to express this molecule 
in a variety of heterologous systems and organisms, has pro- 
vided a particularly useful tool for introducing a fluorescent 
'tag' into proteins and following their intracellular trafficking 
in living cells. A number  of properties of GFP  lend itself for 
this purpose including the intrinsic formation of the fluoro- 
phore in the absence of added co-factor and its monomeric 
nature [17]. On the other hand its relatively large molecular 
mass (27 kDa) compared to chemical f luorophores, could pro- 
mote mis-targeting of the fusion protein, and cause abnormal  
trafficking or sequestration as a result of steric effects. 
In fusing GFP  to either the N- or C-terminus of the insu- 
l in-responsive glucose transporter, GLUT4,  we found that the 
fusion proteins were expressed in a perinuclear location of 
CHO cells and vesicles spread throughout  he cytosol, but 
were excluded from the plasma membrane (Figs. 1 and 2). 
This is an expression pattern which is very similar, at least 
GFP-GLUT4 
Control Insulin 
Fig. 3. lmmunofluorescence analysis of GFP'GLUT4 expressed in 
CHO.T cells. CHO.T cells were microinjected with pGFP.GLUT4 
and incubated in complete medium for 16 h. The cells were serum 
starved for 2 h, and then incubated for 1 h in the absence (a,c) or 
presence (b,d) of 200 nM insulin for 1 h. The cells were fixed, per- 
meabilised and stained with antibody 9El0 as described in Section 
2. The bar represents 10 gm. 












Fig. 4. Internalisation of GLUT4-GFP and GFP.GLUT4 chimeras upon insulin removal. CHO-T cells were microinjected with pGLUT4.GFP 
(a,b,e,f) or pGFP.GLUT4 (c,d,g,h) and incubated in complete medium for 16 h. The cells were incubated in serum-free Ham's F12 medium for 
2 h, followed by 200 nM insulin for 1 h. A fluorescence image was taken in Krebs medium (a~l). The cells were washed thoroughly in serum- 
free DMEM followed by continued incubation in the absence of insulin in serum-free Ham's F12 medium for a further 16 h at 20°C. The 
same cells were then re-imaged (e h). The bar represents 10 lam. 
by fluorescence microscopy, to heterologously expressed na- 
tive GLUT4 in CHO cells [24,25], PC12 cells [26] and 3T3-L1 
cells [27,28], or endogenous GLUT4 in 3T3-L1 cells [27]. 
Previous studies have concluded that GLUT4 possesses at 
least two signals that may be responsible for targeting the 
transporter to this intracellular location in fibroblasts. One, 
a phenylalanine-based (FQQI) motif, is close to the N-termi- 
nus [25,27] and the other, a dileucine motif, is found in the C- 
terminal tail [29,30]; however, other motifs may be involved 
[13]. Mutagenesis of either motif causes GLUT4 to be tar- 
geted to the plasma membrane of cells (reviewed in [3]). The 
close apposition of GFP to either of these motifs did not 
appear to prevent intracellular sequestration (Figs. 1 and 2) 
suggesting either that GFP does not hinder the recognition of 
these motifs by the sorting mechanism, or that other intracel- 
lular sequestration motifs exist on GLUT4 in any one of the 
five intracellular loops of the structure. The latter would be 
consistent with experiments of Ishii et al. [13] who found that 
the middle intracellular loop of GLUT4 provided an addi- 
tional sequestration signal in CHO cells. 
Treatment of cells with insulin promoted an increase in 
plasma membrane fluorescence (Fig. 2). Using immunofluor- 
escence analysis of fixed and permeabilised cells with an anti- 
body that recognised an epitope tag present only within the 
chimeras, we demonstrated this to be the result of net trans- 
location of the chimera to the cell surface (Fig. 3). Both chi- 
meras appeared to respond to a similar extent and thus, again, 
GFP does not appear to hinder the translocation machinery. 
This is, perhaps, not surprising as other proteins (e.g. synap- 
tobrevins and/or SCAMPs) within the GLUT4 containing 
vesicle are likely to be involved in this process [31,32], and 
GLUT4 itself plays only a passive role. 
Of particular interest was the difference in internalisation 
characteristics of the two chimeras. The data shown in Fig. 4 
demonstrate hat fusion of GFP at the N-terminus of GLUT4 
effectively blocked re-internalisation f GLUT4 when insulin 
was removed from the medium. This was in contrast to 
GLUT4 with GFP fused at the C-terminus which exhibited 
an almost compete re-internalisation into a vesicular compart- 
ment (Fig. 4). This data suggests that the major internalisa- 
tion motif is present at the N-terminus of GLUT4, and that 
its interaction with the internalisation machinery is sterically 
hindered by the presence of a large bulky GFP molecule. 
Studies with a chimeric transferrin receptor possessing a cyto- 
plasmic tail derived from the N-terminus of GLUT4 suggest 
that this domain of GLUT4 is involved in efficient internali- 
sation and not subcellular localisation of GLUT4 in CHO 
cells [33]. Our data now suggest hat the N-terminal domain 
of  full-length GLUT4 possesses a critical internalisation motif. 
This motif is likely to be the phenylalanine-based (FQQI) 
sequence which is important for GLUT4 sequestration i  
CHO cells [25] and 3T3-L1 cells [27]. However, we cannot 
completely exclude the possibility that N-terminal GFP also 
sterically hinders the C-terminal dileucine motif; however, this 
is rather unlikely in view of the fact that GFP placed at the C- 
terminus of GLUT4 does not hinder internalisation. 
Our results with the GFP.GLUT4 chimera lso suggest hat 
once synthesised in the endoplasmic reticulum, the chimeric 
transporters are sorted directly into the intracellular compart- 
ment, rather than being exported first to the plasma mem- 
brane and then internalised to the intracellular compartment. 
If the latter were the case, then GFP.GLUT4 would have 
exhibited pronounced plasma membrane localisation in the 
absence of insulin due to its inability to be internalised; this 
was not the case (Figs. lc and 2c,d). 
Our single cell approach to studying insulin action has be- 
gun to reveal a particularly intriguing heterogeneous response 
of the cells to insulin. We always observe a proportion of cells 
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(~  50%) that do not respond to insulin during the course of 
an experiment. We have previously developed an assay for 
insulin-stimulated gene transcription in single living cells [34] 
which was based on the detection of luminescence from 
CHO-T cells microinjected with a plasmid possessing the fire- 
fly luciferase gene under the control of an insulin-responsive 
promoter. We have also observed a similar heterogeneity with 
respect o the induction of luciferase xpression in individual 
cells. Some cells respond rapidly to insulin, others more 
slowly, and some do not respond at all [34]. While the reasons 
for this heterogeneity are not known, we have previously pro- 
posed that it may be due to the point at which the cell is 
within the cell cycle. For example, a protein kinase activity 
may be up-regulated uring one phase of the cell cycle that 
inhibits one of the components of the insulin signalling path- 
way. It will be of particular interest o determine whether cells 
that exhibit a lack of insulin-stimulated GLUT4 trafficking, 
also exhibit a reduced activation of gene transcription. 
In conclusion, therefore, we have demonstrated that 
GLUT4 trafficking can be followed in living cells by generat- 
ing fusion proteins with GFP  attached either at the N- or C- 
terminus of this transporter. Analysis of these chimeras in 
CHO cells suggests a critical role for the GLUT4 N-terminus 
in GLUT4 internalisation from the plasma membrane. 
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